BACTERIA AND THEIR RESISTANCE TO ANTIBIOTICS IN THE INTENSIVE CARE UNIT

Read full article
Article Title: BACTERIA AND THEIR RESISTANCE TO ANTIBIOTICS IN THE INTENSIVE CARE UNIT
Authors: Daniela T. Marți1, 2, Monica Şușan 3, Viorica Lazăr 1, 2, Liliana R. Bran 4, Carmen Neamțu 1, 2, Mirela Ardelean 5, Lucian Negruțiu 1, Adrian Crișan 1, 2, Răzvan Şușan 3, Paul Deme 1, 2, Alexandru Fica Mircea Onel 1, 2
Affiliation: 1Faculty of Medicine, ,,Vasile Goldis” Western University of Arad,
2The Clinical Hospital Emergency of Arad County,
3,,Victor Babeş” University of Medicine and Pharmacy Timişoara,
4University “Aurel Vlaicu” of Arad, Romania,
5„Vasile Goldiş” Western University from Arad, Institute of Life Science, Romania.
Abstract: In 2017, in the intensive care unit the bacteria incidence was bigger at the patients with invasive infections, intubated and catheterized: Acinetobacter baumannii, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, Escherichia coli and MRSA. At most isolated bacteria species we have discovered a multi-resistance, remaining too few therapeutical options according to the antiobiogram. Nosocomial infections are continuing to represent a major problem for the patients safety and therefore introducing a programme for judicious prescriptions of antibiotics (antimicrobial stewardship) in a multidisciplinary hospital.
Keywords: Bacteria, intensive care.
References: 1. Balasa Guragata Carmen, “Prevention of Central Venous Catheter Infections (CVC)”, 2012, https://www.atitimisoara.ro , 82-85, 83-84.
2. Benea Elisabeta-Otilia, Popescu Cristina, Popescu Adrian-Gabriel, ”Angelescu guide. Antimicrobian therapy”, Third Edition, 2012, Bucharest P. 27, P. 30, P. 192-193.
3. CLSI 2017, M100 Performance Standards for Antimicrobial Susceptibility Testing. Laboratory Standards Institute antimicrobial susceptibility testing standards M02-A12, M07-A10 and M11-A8, 27th Edition.
4. Etest Application Sheet, technical information from www.biomerieux.com .
5. EUCAST 2017, “The European Committee for Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters, Version 7.0, 2017. https://www.eucast.org .”
6. George Pankey, Adriana Dornelles, Deborah S Ashcraft, 2013, ”Comparison of 3 Etest® methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species”, in ”Diagnostic microbiology and infectious disease”, August 2013, on RG Journal, 220-226.
7. Licker M., Rus M., Tamas A., et al., 2017.”Emergence of multidrug resistance among Gram negative bacilli from risk departments: actualities and perspectives”, A X A NATIONAL CONFERENCE ON MICROBIOLOGY AND EPIDEMIOLOGY-2017, 62:40.
8. Popescu Adrian-Gabriel, Szekely Edit, Codita Irina et al., 2016,”Diagnosis, Prophylaxis and Treatment of Staphylococcus aureus methicillin-resistant (MRSA) infections”. January 2016, publisher: INSP. Authors and editors: Gabriel- Adrian Popescu at Carol Davilla University of Medicine and Pharmacy, 17-19.
9. Popescu G. Adrian, Serban Roxana, Pistol Adriana, “Consumption of antibiotics, Microbial Resistance and Nosocomial Infections in Romania – 2014”, Bucuresti, 2016, https://www.cnscbt.ro , 27, 30-32, 33-36, 38, 39-40.
10. Szekely Edit, Szasz I. Eva, Vas K. Eszter et al., 2016, “Providencia stuarttii – a success story on the horizon”, A IX A NATIONAL CONFERENCE ON MICROBIOLOGY AND EPIDEMIOLOGY-2016, 61:41-42.
11. ”Surveillance report. Surveillance of antimicrobial resistance in Europe 2016”, https://www.ecdc.eu .
*Correspondence: